Related Experiment Video
Updated: Aug 9, 2026
11:27
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping
1Department of Pharmacology & Toxicology, Institute of Pharmacy and Center of Molecular Biosciences, University of Innsbruck, A-6020 Innsbruck, Austria. nicolas.singewald@uibk.ac.at
Neuroscience and Biobehavioral Reviews
|April 20, 2006
Summary
Rodent models reveal specific brain circuits involved in pathological anxiety. These findings in high-anxiety animals parallel human studies and suggest potential therapeutic targets for anxiety disorders.
Area of Science:
- Neuroscience
- Behavioral Science
- Psychiatry
Background:
- Pathological anxiety is linked to abnormal emotional information processing within fear/anxiety pathways.
- Understanding the neurobiological underpinnings of anxiety disorders is crucial for developing effective treatments.
Purpose of the Study:
- To investigate neurobiological substrates of anxiety using rodent models.
- To identify brain regions with differential neuronal activation in high-anxiety versus low-anxiety rodents.
Main Methods:
- Utilized functional mapping techniques in various rodent models (e.g., selected lines, genetically modified animals).
- Applied diverse emotional challenges to identify specific neural circuitries involved in fear and anxiety responses.
Main Results:
- Differential neuronal activation was observed in specific fear/anxiety circuitry regions in high-anxiety rodents compared to controls.
- Findings indicate that distinct emotional challenges engage particular brain areas within the fear/anxiety circuitry.
- Identified neuronal substrates show parallels with human studies on anxiety disorders.
Conclusions:
- Rodent models provide valuable insights into the neurobiology of pathological anxiety.
- Specific brain areas and neuronal populations are implicated as mediators of dysfunctional brain activation in anxiety.
- Early research suggests potential therapeutic targets and neurochemical pathways for anxiolysis.
